Back to Course
Internal Medicine 101
0% Complete
0/0 Steps
-
Pneumonia
Community-Acquired Pneumonia9 Topics|3 Quizzes-
Pre-Quiz: Community-Acquired Pneumonia
-
Background
-
Epidemiology, Risk Factors, and Etiology
-
Pathophysiology and Clinical Manifestations
-
Diagnostic Tests
-
Treatment and Management
-
Literature Review: Community-Acquired Pneumonia
-
Post-Quiz: Community-Acquired Pneumonia
-
Post-Lesson Feedback Survey for Internal Medicine 101: Community-Acquired Pneumonia
-
Pre-Quiz: Community-Acquired Pneumonia
-
Venous Thromboembolic DiseaseAcute Management of Pulmonary Embolism12 Topics|2 Quizzes
-
Pre-Quiz: Acute Management of Pulmonary Embolism
-
Introduction
-
Epidemiology and Pathophysiology
-
Clinical Presentation
-
Diagnosis and Risk Stratification
-
General Approaches
-
Anticoagulation in Acute Pulmonary Embolism with Literature Review
-
Thrombolytic Therapy in Acute Pulmonary Embolism with Literature Review
-
Ancillary Therapies in the Management of Pulmonary Embolism
-
Summary and References
-
Post-Quiz: Acute Management of Pulmonary Embolism
-
Post-Lesson Feedback Survey for Internal Medicine 101: PE
-
Pre-Quiz: Acute Management of Pulmonary Embolism
-
Acute Management of DVT10 Topics|2 Quizzes
-
Diabetes and HyperglycemiaHyperglycemia in Hospitalized Patients11 Topics|2 Quizzes
-
Pre-Quiz: Hyperglycemia in Hospitalized Patients
-
Introduction
-
Clinical Presentation
-
Pathophysiology
-
Diagnostic Approach
-
Pharmacotherapy
-
Management of Hypoglycemia in Hospitalized Patients
-
Literature Review: Key Guidelines and Studies for Hyperglycemia in Hospitalized Patients
-
Summary and References
-
Post-Quiz: Hyperglycemia in Hospitalized Patients IM 101
-
Post-Lesson Feedback Survey for Internal Medicine 101: Hyperglycemia
-
Pre-Quiz: Hyperglycemia in Hospitalized Patients
-
Hyperglycemic Crisis: Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome13 Topics|3 Quizzes
-
Pre-Quiz: Hyperglycemic Crisis: Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome
-
Introduction
-
Clinical Presentation
-
Pathophysiology
-
Risk Factors and Precipitating Triggers
-
Diagnostic Approach
-
Fluid Resuscitation
-
Insulin Therapy
-
Hypoglycemia Management
-
Literature Review: Hyperglycemic Crisis
-
References
-
Post-Quiz: Hyperglycemic Crisis: Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome IM 101
-
Post-Lesson Feedback Survey for Internal Medicine 101: DKA & HHS
-
Pre-Quiz: Hyperglycemic Crisis: Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome
-
Pulmonary ExacerbationsChronic Obstructive Pulmonary Disease Exacerbation10 Topics|3 Quizzes
-
Pre-Quiz: Chronic Obstructive Pulmonary Disease Exacerbation
-
Introduction to COPD Exacerbation
-
Pathophysiology of COPD Exacerbation
-
Clinical Manifestations
-
Diagnostic Criteria and Assessment
-
Management
-
Literature Review: Key Guidelines and Studies
-
Summary and References
-
Post-Quiz: Chronic Obstructive Pulmonary Disease Exacerbation
-
Post-Lesson Feedback Survey for Internal Medicine 101: COPD
-
Pre-Quiz: Chronic Obstructive Pulmonary Disease Exacerbation
-
Asthma Exacerbation15 Topics|3 Quizzes
-
Pre-Quiz: Asthma Exacerbation
-
Introduction to Asthma Exacerbation
-
Pathophysiology
-
Risk Factors and Precipitating Triggers
-
Clinical Manifestations
-
Diagnostic Criteria and Assessment
-
Non-Pharmacological Management
-
Pharmacological Management
-
Complications and Emergency Management
-
Monitoring and Follow-up
-
Discharge Planning and Patient Education
-
Literature Review: Asthma Exacerbation
-
Summary and References
-
Post-Quiz: Asthma Exacerbation
-
Post-Lesson Feedback Survey for Internal Medicine 101: Asthma Exacerbation
-
Pre-Quiz: Asthma Exacerbation
Participants 396
Lesson 1,
Topic 6
In Progress
Treatment and Management
Lesson Progress
0% Complete
For patients with a working diagnosis of CAP, management relies on defining the severity of the illness to determine the most appropriate approach. The severity of illness is based on clinical judgment and can be supplemented by the use of severity scores such as the Pneumonia Severity Index (PSI) and CURB-65, in which PSI or PORT score is more preferred.
Pneumonia Severity Index / PSI or PORT Score
CURB-65 Scoring
CAP Initial Evaluation and Site of Care Based on Severity Assessments
Empiric Antibiotic Therapy: Outpatient
- Patients are often treated for 5 days.
- Ensure that all patients are responding positively to antibiotic therapy and remain afebrile for at least 48 hours before stopping antibiotics.
Empiric Antibiotic Therapy: Inpatient (Ward or ICU)
- First-line: Beta-lactam + Macrolide or Respiratory Fluoroquinolone
- Antibiotic therapy should be initiated within 4 to 8 hours of hospital arrival for patients with radiographically confirmed pneumonia and moderate to high levels of illness severity presentation.
- Identify risk factors to begin empiric antibiotic therapy.
Adjunctive Glucocorticoids
- For patients with as septic shock with one or more of the following:
- Metabolic acidosis, arterial pH <7.3
- Lactate <4 mmol/L
- C-reactive protein > 150 mg/L
Factors Relevant to Initial Antibiotic Therapy
- Disposition
- Patients generally make clinical improvements within 48 – 72 hours. Further management is dictated by the patient’s response to initial empiric therapy. Make daily assessments on clinical response and improvements on cough, sputum production, dyspnea, and chest pain. Also assess for resolution of fever and normalization of heart rate, RR, and WBC count.
- Antibiotic Deescalation
- Tailor therapy to attack the pathogen. If not present, continue empiric antibiotic therapy until patient shows signs of improvements.
- Duration of Therapy
- This is often based on the patient’s response to therapy. All patients are generally treated for 48 hours to a minimum of 5 days and until they are afebrile and clinically stable.
- Mild infections – 5 – 7 days of therapy
- Severe infections or chronic comorbidities: 7 – 10 days of therapy
- Extended courses may be needed for immunocompromised patients, those with causative pathogen involvement, or those with complications.
- This is often based on the patient’s response to therapy. All patients are generally treated for 48 hours to a minimum of 5 days and until they are afebrile and clinically stable.
- Discharge
- Only recommended if patient is clinically stable, can take oral medications, has no other active medical problems, and has a safe environment for continued care.
- Criteria for clinical stability:
- Temperature ≤37.8◦C
- HR ≤100bpm
- RR ≤24brpm
- Systolic BP ≥90mmHg
- Arterial O2 Saturation ≥90% or pO2 ≥60 mmHg on room air
Antibiotic Therapy for CAP
References:
1. Ramirez, et al. Overview of Community-Acquired Pneumonia in Adults. 2021